These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 22752373)
1. Prognostic relevance of occult metastases detected by cytokeratin 20 and mucin 2 mRNA levels in sentinel lymph nodes from colon cancer patients. Nordgård O; Oltedal S; Aasprong OG; Søreide JA; Søreide K; Tjensvoll K; Gilje B; Heikkilä R; Guriby M; Lothe RA; Smaaland R; Kørner H Ann Surg Oncol; 2012 Nov; 19(12):3719-26. PubMed ID: 22752373 [TBL] [Abstract][Full Text] [Related]
2. Quantitative RT-PCR detection of tumor cells in sentinel lymph nodes isolated from colon cancer patients with an ex vivo approach. Nordgård O; Oltedal S; Kørner H; Aasprong OG; Tjensvoll K; Gilje B; Heikkilä R Ann Surg; 2009 Apr; 249(4):602-7. PubMed ID: 19300229 [TBL] [Abstract][Full Text] [Related]
3. Detection of occult metastases in sentinel lymph nodes from colon cancer patients by K-ras mutation peptide nucleic acid clamp PCR. Oltedal S; Gilje B; Kørner H; Aasprong OG; Tjensvoll K; Heikkilä R; Smaaland R; Nordgård O Ann Surg; 2010 Jun; 251(6):1087-91. PubMed ID: 20485143 [TBL] [Abstract][Full Text] [Related]
4. The potential of cytokeratin 20 and mucin 2 mRNA as metastasis markers in regional lymph nodes of colon cancer patients investigated by quantitative RT-PCR. Nordgård O; Oltedal S; Kørner H; Aasprong OG; Tjensvoll K; Gilje B; Heikkilä R Int J Colorectal Dis; 2009 Mar; 24(3):261-8. PubMed ID: 19119477 [TBL] [Abstract][Full Text] [Related]
5. Ex vivo sentinel lymph node mapping in colon cancer: improving the accuracy of pathologic staging? Smith J; Hwang H; Wiseman KW; Filipenko D; Phang PT Am J Surg; 2006 May; 191(5):665-8. PubMed ID: 16647356 [TBL] [Abstract][Full Text] [Related]
6. Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine. Kumagai R; Kohashi K; Takahashi S; Yamamoto H; Hirahashi M; Taguchi K; Nishiyama K; Oda Y World J Gastroenterol; 2015 Mar; 21(9):2700-10. PubMed ID: 25759539 [TBL] [Abstract][Full Text] [Related]
11. Influence of microsatellite instability and KRAS and BRAF mutations on lymph node harvest in stage I-III colon cancers. Berg M; Guriby M; Nordgård O; Nedrebø BS; Ahlquist TC; Smaaland R; Oltedal S; Søreide JA; Kørner H; Lothe RA; Søreide K Mol Med; 2013 Sep; 19(1):286-93. PubMed ID: 23979710 [TBL] [Abstract][Full Text] [Related]
12. Detection of micrometastases and skip metastases with ex vivo sentinel node mapping in carcinoma of the colon and rectum. Yagci G; Unlu A; Kurt B; Can MF; Kaymakcioglu N; Cetiner S; Tufan T; Sen D Int J Colorectal Dis; 2007 Feb; 22(2):167-73. PubMed ID: 16721490 [TBL] [Abstract][Full Text] [Related]
13. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability. Umeda Y; Nagasaka T; Mori Y; Sadamori H; Sun DS; Shinoura S; Yoshida R; Satoh D; Nobuoka D; Utsumi M; Yoshida K; Yagi T; Fujiwara T J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):223-33. PubMed ID: 23010994 [TBL] [Abstract][Full Text] [Related]
14. Detection of lymph node micrometastases and isolated tumor cells in sentinel and nonsentinel lymph nodes of colon cancer patients. Bembenek A; Schneider U; Gretschel S; Fischer J; Schlag PM World J Surg; 2005 Sep; 29(9):1172-5. PubMed ID: 16091983 [TBL] [Abstract][Full Text] [Related]
15. Clinical application of sentinel lymph node biopsy for staging, treatment and prognosis of colon and gastric cancer. Dragan R; Nebojsa M; Dejan S; Ivan P; Dragos S; Damir J; Predrag S; Vladan Z Hepatogastroenterology; 2009; 56(96):1606-11. PubMed ID: 20214202 [TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of an epigenetic biomarker panel in sentinel lymph nodes from colon cancer patients. Lind GE; Guriby M; Ahlquist T; Hussain I; Jeanmougin M; Søreide K; Kørner H; Lothe RA; Nordgård O Clin Epigenetics; 2017; 9():97. PubMed ID: 28878843 [TBL] [Abstract][Full Text] [Related]
17. The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer. Lin CC; Lin JK; Lin TC; Chen WS; Yang SH; Wang HS; Lan YT; Jiang JK; Yang MH; Chang SC J Surg Oncol; 2014 Sep; 110(4):451-7. PubMed ID: 24964758 [TBL] [Abstract][Full Text] [Related]
18. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer. Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237 [TBL] [Abstract][Full Text] [Related]
19. Stage III & IV colon and rectal cancers share a similar genetic profile: a review of the Oregon Colorectal Cancer Registry. Gawlick U; Lu KC; Douthit MA; Diggs BS; Schuff KG; Herzig DO; Tsikitis VL Am J Surg; 2013 May; 205(5):608-12; discussion 612. PubMed ID: 23592171 [TBL] [Abstract][Full Text] [Related]
20. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma. Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]